Providing for consideration of the bill (H.R. 6199) to amend the Internal Revenue Code of 1986 to include certain over-the-counter medical products as qualified medical expenses, and providing for proceedings during the period from July 27, 2018, through September 3, 2018.

Bill 115 HRES 1012 is a resolution that sets forth the procedures for considering a specific bill, H.R. 6199, which aims to amend the Internal Revenue Code of 1986. The purpose of H.R. 6199 is to classify certain over-the-counter medical products as qualified medical expenses. This means that individuals would be able to use funds from their health savings accounts or flexible spending accounts to purchase these products without facing tax penalties.

The resolution, HRES 1012, also outlines the schedule for congressional proceedings from July 27, 2018, through September 3, 2018. This includes the timeline for debating and voting on H.R. 6199, as well as any other legislative matters that may arise during this period.

Overall, Bill 115 HRES 1012 is focused on facilitating the consideration of H.R. 6199 and ensuring that the legislative process runs smoothly during the specified timeframe. It is aimed at addressing the issue of over-the-counter medical products and their classification as qualified medical expenses under the Internal Revenue Code.